Cyprus-Life Insurance-To 2017-Market Growth,Key Trends And Opportunities

After remaining largely unscathed by the global financial and eurozone debt crisis, the Cypriot banking sector succumbed to pressure in 2012 triggered by huge losses from investments in Greek sovereign and corporate bonds. The depressed economic environment led to a sharp decline in employment levels, leading to erosion in consumer confidence and spending. The recessionary economic conditions eroded demand for life insurance products with the segment’s gross written premium falling by 7.1% in 2012. The life segment accounted for the largest share with 39.7% of the written premium of the overall insurance industry in 2012.
http://www.marketresearchreports.biz/analysis/192675

Market Survey-Reinsurance In Cyprus, Key Trends And Opportunities To 2017

The Cypriot reinsurance segment registered a compound annual growth rate (CAGR) of 8.1% during the review period (2008–2012). The primary application of reinsurance in Cyprus is to manage exposure to weather-related events. Although not particularly vulnerable to natural disasters, Cyprus is highly exposed to floods, storms, extreme temperatures and earthquakes. The majority of reinsurance revenues are generated from the non-life segment, which ceded an average of 35.0% of its written premium during the review period, compared with 11.8% and 24.8% for the life and personal accident and health segments.
http://www.marketresearchreports.biz/analysis/192671

The Pharmaceutical Market: Russia, Spain, United Kingdom, India, Finland : Market Research Reports

          Market Research Reports.Biz announces addition of new report “ Pharmaceutical Market ” to its database.

The Russia, Spain, United Kingdom, India, Finland pharmaceutical market remains a powerhouse in the Emerging Europe region . The country has by far the largest population in the region. I ts resource s -driven economic growth is funding both private and public spending on medicines and healthcare services. The country's World Trade Organisation (WTO) accession has eliminated tariff barriers and should, in the long run, drive major improvements in a problematic intellectual property environment.

Visit Same Publisher Report: The Pharmaceutical Market: Russia, Spain, United Kingdom, India, Finland

Both domestic and cross-border mergers and acquisitions (M&A) activity has picked up since the 2009 economic crisis, a result of increased incentives for local production under the government's industrial policy for the sector and the need for scale to compete , especially in the generic medicines market. We believe a critical forward step for the market will be the successful implementation of a broad-based medicines insurance programmer in the next few years, following current pilot projects. If this proves successful, we would expect growth to outstrip our current five-year projection for a compound annual growth rate of 8.3% in US dollar terms during the period 2012-2017.

For More Latest Reports Under the Same Category: Pharmaceutical Market

Headline Expenditure Projections

Pharmaceuticals: RUB664.72bn (US$20.96bn) in 2012 to RUR728.00bn (US$22.40bn) in 2013; +9.5% in local currency terms and 6.9% in US dollar terms. Forecast is virtually unchanged from Q412.
Healthcare: RUB2,709.62 (US$85.42bn) in 2012 to RUB2928.54bn (US$90.11bn) in 2013; +8.1% in local currency terms and +5.5% in US dollar terms. Forecast is virtually unchanged from Q412.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Table of Content

Executive Summary
SWOT Analysis
Russia, Spain, United Kingdom, India, Finland Pharmaceuticals And Healthcare Industry SWOT
Russia, Spain, United Kingdom, India, Finland Political SWOT
Russia, Spain, United Kingdom, India, Finland Economic SWOT
Russia, Spain, United Kingdom, India, Finland Business Environment SWOT
Pharmaceutical Risk/Reward Ratings
Table: CEE Pharmaceutical Risk/Reward Ratings, Q213
Competitive Landscape
Manufacturing Sector
Company Activity
Wholesale Sector
Retail Sector
Company Profiles
Berlin-Chemie/Menarini Pharma GmbH

About Us

Market Research Reports.biz is the most comprehensive collection of market research reports. Market Research Reports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: +1-866-997-4948

Browse Market Research Blog:

Blog: Markets News

Blog: All Business Research Reports

Blog: Global Business Research Reports

Blog: GLOBAL AND CHINA INDUSTRY 2014